Timolol Maleate Gel for the Treatment of Infantile Hemangioma
Clinical trial NCT06677853 · COMPLETED
Trial details
- NCT number
- NCT06677853
- Sponsor
- Auson Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-28
- Primary completion
- 2022-06-21
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.